64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients-Reference-Cited by-同舟云学术

64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

Published:2015-03-12 Issue:1 Volume:5 Page:
ISSN:2191-219X
Container-title:EJNMMI Research
language:en
Short-container-title:EJNMMI Res

Author:

Kurihara Hiroaki,Hamada Akinobu,Yoshida Masayuki,Shimma Schuichi,Hashimoto Jun,Yonemori Kan,Tani Hitomi,Miyakita Yasuji,Kanayama Yousuke,Wada Yasuhiro,Kodaira Makoto,Yunokawa Mayu,Yamamoto Harukaze,Shimizu Chikako,Takahashi Kazuhiro,Watanabe Yasuyoshi,Fujiwara Yasuhiro,Tamura Kenji

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1186/s13550-015-0082-6.pdf

Reference26 articles.

1. Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al.: Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2–positive operable breast cancer. J Clin Oncol 2005, 23: 3676–85. 10.1200/JCO.2005.07.032

2. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al.: Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005, 353: 1673–84. 10.1056/NEJMoa052122

3. Tripathy D, Slamon DJ, Cobleigh M, Arnold A, Saleh M, Mortimer JE, et al.: Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J Clin Oncol 2004, 22: 1063–70. 10.1200/JCO.2004.06.557

4. Sauter G, Lee J, Bartlett JM, Slamon DJ, Press MF: Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol 2009, 27: 1323–33. 10.1200/JCO.2007.14.8197

5. Lebeau A, Turzynski A, Braun S, Behrhof W, Fleige B, Schmitt WD, et al.: Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies. J Clin Oncol 2010, 28: 3264–70. 10.1200/JCO.2009.25.9366

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads;International Journal of Molecular Sciences;2024-08-08

2. Brain metastasis: An insight into novel molecular targets for theranostic approaches;Critical Reviews in Oncology/Hematology;2024-06

3. BRAF V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximab;CNS Oncology;2024-05-20

4. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11

5. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19